Retired business executive Larry Woelk has been a long-term participant in the trial for Alzheimer’s drug lecanemab , having received it for around five years.

The 78-year-old, originally from Dodge City, Kansas, lives in North Hampshire with his wife Rita. He was diagnosed with mild cognitive impairment in 2018 after having problems with his memory and difficulties absorbing information.

He joined the first trial for lecanemab in 2020 and then went onto the extended trial, receiving the drug every two weeks via an IV infusion. New Feature

In Short

Quick Stories. Same trusted journalism.

Larry – who met his wife in Boston in 1970 while they worked in the same hospital – is one of just a few people in the UK who have had access to lecanemab via a clinical trial, which he is due to c

See Full Page